000 | 01676 a2200481 4500 | ||
---|---|---|---|
005 | 20250514222210.0 | ||
264 | 0 | _c20050901 | |
008 | 200509s 0 0 eng d | ||
022 | _a1567-5769 | ||
024 | 7 |
_a10.1016/j.intimp.2005.01.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBuluc, M | |
245 | 0 | 0 |
_aEffect of Candida albicans septicemia on the cardiovascular function of rabbits. _h[electronic resource] |
260 |
_bInternational immunopharmacology _cMay 2005 |
||
300 |
_a893-901 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta, Thoracic _xpathology |
650 | 0 | 4 |
_aCandidiasis _xpathology |
650 | 0 | 4 | _aCardiovascular Physiological Phenomena |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFungemia _xpathology |
650 | 0 | 4 |
_aHeart Atria _xdrug effects |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardium _xpathology |
650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aNitric Oxide Synthase Type III |
650 | 0 | 4 |
_aPapillary Muscles _xdrug effects |
650 | 0 | 4 | _aRabbits |
700 | 1 | _aAtaoğlu, H | |
700 | 1 | _aDoğan, D | |
700 | 1 | _aErgün, H | |
700 | 1 | _aGürdal, H | |
700 | 1 | _aErdemli, E | |
700 | 1 | _aDemirel-Yilmaz, E | |
773 | 0 |
_tInternational immunopharmacology _gvol. 5 _gno. 5 _gp. 893-901 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2005.01.010 _zAvailable from publisher's website |
999 |
_c15450133 _d15450133 |